Joinn Laboratories (06127) reported a net profit attributable to shareholders of 2.38 billion yuan in the first quarter, an increase of 479.67% year-on-year.
Zhao Yan New Drug (06127) released its first quarter report for 2026, with operating income of 316 million yuan, an increase of 10.02% year-on-year; net profit attributable to parent company was 238 million yuan, an increase of 479.67% year-on-year; basic earnings per share were 0.32 yuan.
Joinn Laboratories (06127) released its first quarter report for 2026, with operating income of 316 million yuan, a year-on-year increase of 10.02%; net profit attributable to shareholders was 238 million yuan, a year-on-year increase of 479.67%; basic earnings per share was 0.32 yuan.
Related Articles
GREEN TEA GROUP (06831) spent approximately HK$722,300 to repurchase 84,400 shares on April 29th.
ZYLOXTB (02190) spent HKD 1.1324 million to repurchase 50,000 shares on April 29th.
On April 29, SHOUHUI GROUP (02621) spent HK$90,400 to repurchase 28,800 shares.
GREEN TEA GROUP (06831) spent approximately HK$722,300 to repurchase 84,400 shares on April 29th.
ZYLOXTB (02190) spent HKD 1.1324 million to repurchase 50,000 shares on April 29th.
On April 29, SHOUHUI GROUP (02621) spent HK$90,400 to repurchase 28,800 shares.
RECOMMEND
